The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Lethargy

Lethargy

Lethargy is a state of abnormal drowsiness, sluggishness, or lack of energy.
It can be a symptom of various underlying medical conditions, such as infection, hypothyroidism, depression, or chronic fatigue syndrome.
Lethargy can interfere with daily activities and negatively impact quality of life.
Effective treatment involves identifying and addressing the underlying cause.
Proper rest, hydration, and management of any underlying conditions are often recommended to overcome lethargy and restore energy levels.
Seeking medical evaluation is advisible if lethargy persists or interferes with normal functioning.

Most cited protocols related to «Lethargy»

The ABC-C is a 58-item rating scale used to assess maladaptive behaviors
across five original dimensions or subscales: Irritability, Hyperactivity,
Lethargy/Withdrawal, Stereotypy, and Inappropriate Speech. Items are evaluated
on a four-point Likert scale ranging from 0 (not at all a problem) to 3 (the
problem is severe in degree). The first Aberrant Behavior Checklist
(ABC-Residential) was developed to measure treatment efficacy among individuals
with developmental disabilities living in residential facilities (Aman et al. 1985 (link)). The five subscales were
empirically derived using factor analysis in a sample of 927 residents of
institutions or homes serving individuals with developmental disabilities
(65% male, average age = 25.9 years). This original version was later
modified and items specific to an institutional setting were revised to apply to
a community setting. The factor structure and strong psychometric properties of
the ABC-R are preserved in the ABC-C and are robust for both genders and across
various ages (Aman et al. 1995 (link); Brown et al. 2002 (link); Marshburn and Aman 1992 (link); Ono 1996 ).
Publication 2011
Aman Developmental Disabilities Disabled Persons Lethargy Males Psychometrics Speech Stereotypic Movement Disorder
Full details of the methods, along with sensitivity and uncertainty analyses, are provided in Supplementary Appendix 1, available with the full text of this article at NEJM.org; a summary is provided here. Case definitions for EVD have been reported previously by the WHO.9 In brief, a suspected case is illness in any person, alive or dead, who has (or had) sudden onset of high fever and had contact with a person with a suspected, probable, or confirmed Ebola case or with a dead or sick animal; any person with sudden onset of high fever and at least three of the following symptoms: headache, vomiting, anorexia or loss of appetite, diarrhea, lethargy, stomach pain, aching muscles or joints, difficulty swallowing, breathing difficulties, or hiccupping; or any person who had unexplained bleeding or who died suddenly from an unexplained cause. A probable case is illness in any person suspected to have EVD who was evaluated by a clinician or any person who died from suspected Ebola and had an epidemiologic link to a person with a confirmed case but was not tested and did not have laboratory confirmation of the disease. A probable or suspected case was classified as confirmed when a sample from the person was positive for Ebola virus in laboratory testing.
Clinical and demographic data were collected with the use of a standard case investigation form (see Supplementary Appendix 1) on confirmed, probable, and suspected EVD cases identified through clinical care, including hospitalization, and through contact tracing in Guinea, Liberia, Nigeria, and Sierra Leone. To create the fullest possible picture of the unfolding epidemic, these data were supplemented by information collected in informal case reports, by data from diagnostic laboratories, and from burial records. The data recorded for each case included the district of residence, the district in which the disease was reported, the patient’s age, sex, and signs and symptoms, the date of symptom onset and of case detection, the name of the hospital, the date of hospitalization, and the date of death or discharge. A subgroup of case patients provided information on potentially infectious contacts with other persons who had Ebola virus disease, including possible exposure at funerals. We present here the results from analyses of detailed data on individual confirmed and probable cases recorded by each country in databases provided to the WHO as of September 14, 2014; analyses of confirmed and probable cases, together with suspected cases, are provided in Supplementary Appendix 1.
Publication 2014
Abdominal Pain Animals Anorexia Diagnosis Diarrhea Ebolavirus Epidemics Fever Headache Hemorrhagic Fever, Ebola Hospitalization Hypersensitivity Infection Joints Lethargy Muscle Tissue Patient Discharge Patients
This hospital based unmatched case control study was conducted in Mekelle City, North Ethiopia, which is located at 783km from Addis Ababa (the capital city of Ethiopia) since December 2014 to June 2015. The study was carried out among neonates who were admitted to public hospitals of the city.
The hematological criteria along with the established IMNCI (Integrated Management of Neonatal and Childhood Illness) clinical features of neonatal sepsis were used to diagnose neonatal sepsis in this study. Neonates in the presence of one or more of the established IMNCI clinical features [either of fever (≥37.5°C) or hypothermia (≤ 35.5°C), fast breathing (≥60 breath per minute), severe chest indrawing, not feeding well, movement only when stimulated, convulsion, lethargic or unconscious] along with ≥ 2 of the hematological criteria; total leukocyte count (<4000 or >12000 cells/m3, absolute neutrophil count (<1500 cells/mm3 or >7500 cells/mm3), erythrocyte sedimentation rate (ESR) (>15/1 h) and platelet count (<150 or >440 cells/m3) and who were admitted to pediatric ward or neonatal ICU of the public hospitals of Mekelle City, North Ethiopia during the study period were included with their index mothers as cases. Neonates who were not fulfilled the criteria of sepsis and who were admitted to pediatric ward or neonatal ICU of the public hospitals in Mekelle City, North Ethiopia during the study period were also included with their index mothers as controls.
A two population proportion formula (using open Epi version 2.3.1) was used to estimate the sample size required for the study by considering that the proportion of mothers with UTI/ STI among the controls of 13% (main exposure variable), which was estimated from another study [13 ], 95% CI, 80% power of the study control to case ratio of 2:1 to detect an odds ratio of 2.87 which was estimated from a study done by others [13 ]. Accordingly, by adding 5% for the non response rate, 78 cases and 156 controls (a total sample size of 234) was the estimated sample size in this study. Cases and controls were selected using proportional systematic random sampling.
Data was collected using semi structured questionnaire and checklist prepared in English and then translated to the local language, Tigrigna (S1 Appendix). The tool was pretested on 5% (4 cases and 8 controls) of the sample size before the actual data collection period. The data were collected by 4 nurses with previous experiences and after being trained by the principal investigator about the purpose of the study and how to interview as well as fill the questionnaire and checklist properly. Finally, the data collectors collected the data through interviewing the mothers and reviewing neonates’ medical records throughout the data collection period.
The data were checked for completeness, inconsistencies, then entered using Epi-Info version 7 and cleaned and analyzed in SPSS version 20. Cross tabulation was done to see the distribution of cases and controls. The binary logistic regression model was used to test the association between dependent and independent variables. All variables with P value <0.29 in bivariate analysis were included in the multivariable analysis. Magnitude of association was measured by using an odds ratio at 95% confidence interval. Statistical significance was declared at P<0.05. Finally, the data are presented with texts and tables.
Full text: Click here
Publication 2016
Cells Chest Diagnosis Fever Infant, Newborn Lethargy Leukocyte Count Mothers Movement Neutrophil Nurses Platelet Counts, Blood Sedimentation Rates, Erythrocyte Seizures Sepses, Neonatal Septicemia Specimen Collection
The production of ECTV stocks for infection of mice and the determination of titers in stocks and organs were done as described previously [8 (link)]. To generate ECTV 189898-p7.5-EGFP, we adapted the method described by Johnston and McFadden [60 (link)]. Briefly, a construct containing the ECTV Moscow fragment 189543–189897, the VACV early/late promoter p7.5, the sequence of EGFP, and the ECTV Moscow fragment 189950–190297, in that order, was made by recombinant PCR and cloned into plasmid Bluescript II SK+ to generate the targeting vector pBS-EVM189898-p7.5-EGFP. This targeting vector was used to transfect mouse A9 cells using Lipofectamine 2000 as per manufacturer's instructions (Invitrogen). The transfected cells were infected with wild-type ECTV (Moscow strain, 0.3 pfu/cell) in 6-well plates. 2 d later, transfected/infected A9 cells were harvested using a rubber policeman, frozen and thawed, and different dilutions of cell lysates were used to infect BSC-1 cells in 6-well plates. 2 h after infection, the cells were overlaid with media containing 0.5% agarose. 4 d later, green-fluorescent plaques were picked with a pipette tip and used to infect a new set of cells. The purification procedure was iterated five times until all plaques were fluorescent. The resulting virus, ECTV 189898-p7.5-EGFP, carries EGFP in a non-coding region and is as pathogenic as wild-type ECTV Moscow (not shown). For preparation of ECTV stock for infection of different cell lines, A9 cells were infected with 0.2 pfu ECTV/cell, and incubated at 37 °C, 5% CO2. After 5 d, the cells were collected, frozen and thawed three times, and then sonicated in a water-bath sonicator. The solid material was pelleted by centrifugation, and the supernatant was stored in aliquots at −80 °C. The DAP10-deficient mice [61 (link),62 (link)] (generously provided by Dr. Joe Phillips) and DAP12-deficient mice [63 (link)] on the C57BL/6 background were bred at UCSF. All the other mice were bred at the Fox Chase Cancer Center Laboratory Animal Facility in specific pathogen-free rooms or were purchased from Jackson Laboratories. IFN-γ-deficient C57BL/6 mice were generously provided by Dr. Glenn Rall. For infections, sex-matched animals 8–12 wk old were transferred to a biosafety level 3 room. For ECTV infection, anesthetized mice were infected in the left footpad with 25 μl PBS containing 3 × 103 pfu ECTV. Following infections, mice were observed daily for signs of disease (lethargy, ruffled hair, weight loss, skin rash, and eye secretions) and imminent death (unresponsiveness to touch and lack of voluntary movements). Moribund mice were euthanized by halothane inhalation. All of the experimental protocols involving animals were approved by the Fox Chase Cancer Center Institutional Animal Care and Use Committee.
For ECTV infection of cells, 3–5 × 105 cells were plated in 6-well plates and cultured overnight to allow cells to adhere. The cells were then infected with 0.5 pfu ECTV/cell for 18 h, collected, washed, stained, and analyzed for surface expression of various markers. For ECTV infection of peritoneal cells, the mice were euthanized by halothane inhalation and injected i.p. with PBS, the abdomen massaged gently, and the peritoneal cells were collected by aspiration and washed.
Full text: Click here
Publication 2008
Abdominal Cavity Animals Animals, Laboratory Bath Cell Lines Cells Centrifugation Cloning Vectors Exanthema Freezing Hair Halothane Infection Inhalation Institutional Animal Care and Use Committees Interferon Type II Lethargy lipofectamine 2000 Malignant Neoplasms Mice, Inbred C57BL Movement Mus Pathogenicity Peritoneum Plasmids Rubber Secretions, Bodily Senile Plaques Sepharose Specific Pathogen Free Strains Technique, Dilution Touch Virus
The social isolation scale used by the UK Biobank was constructed from three questions: (1) “Including yourself, how many people are living together in your household? Include those who usually live in the house such as students living away from home during term time, partners in the armed forces or professions such as pilots” (1 point for living alone); (2) “How often do you visit friends or family or have them visit you?” (1 point for friends and family visit less than once a month); and (3) “Which of the following [leisure/social activities] do you engage in once a week or more often? You may select more than one” (1 point for no participation in social activities at least weekly). Thus, individuals could score a total of 0–3; an individual was defined as socially isolated if he or she scored 2 or 3; those who scored 0 or 1 were classified as not isolated. Similar scales have been used previously in other UK studies.12 (link)
Loneliness was assessed with two questions: “Do you often feel lonely?” (no=0, yes=1) and “How often are you able to confide in someone close to you?” (0=almost daily to once every few months; 1=never or almost never). An individual was defined as lonely if he or she scored 2, and not lonely if he or she scored 0 or 1. Similar questions are included in scales such as the revised UCLA Loneliness Scale.13 (link)
Follow-up for all deaths irrespective of cause started at inclusion in the UK Biobank study (from national death registers) and ended on Aug 14, 2015, or upon death, for all participants. The cause-specific-mortality International Classification of Diseases (ICD) codes were as follows: neoplasms (C00–D48), diseases of the circulatory system (I05–I89), and other diseases (all remaining ICD-10 codes).
Details of the assessments of participants' variables are publicly available.14 Briefly, participants completed several touch-screen computer-based questionnaires, and then had a face-to-face interview with a trained researcher. The information collected included basic demographics (sex and age), ethnic origin (white vs other), socioeconomic factors (educational attainment, household income, and postcode of residence with the corresponding Townsend deprivation index score), and chronic diseases (diabetes, cardiovascular disease, cancer, and other long-standing illness, disability, or infirmity). The Townsend deprivation index is an integrated neighbourhood-level measure of unemployment, non-car ownership, non-home ownership, and household overcrowding across the UK.15 (link)
To assess biological factors, trained data collectors measured height and weight in all participants during clinic attendance using standard operating procedures, and the body-mass index (BMI) was subsequently calculated. Procedures for measuring systolic and diastolic blood pressure and handgrip strength are reported in the UK Biobank protocol, which is available online.11 (link) Behavioural factors, including cigarette smoking (current smoker [yes or no]; ex-smoker [yes or no]), physical activity (moderate and vigorous), and alcohol intake frequency (at least three times a week vs twice a week or less) were self-reported on a questionnaire.
Psychological factors comprised current depressive symptoms and general cognitive capacity. Depressive symptoms were measured using the frequency of four items from the Patient Health Questionnaire (PHQ):16 (link), 17 (link) (1) depressed mood, (2) disinterest or absence of enthusiasm, (3) tenseness or restlessness, and (4) tiredness or lethargy in the previous 2 weeks. General cognitive capacity (numeric memory, verbal–numerical reasoning, reaction time, and visual memory) was assessed by use of a touch-screen application.18 (link) Self-rated health was assessed using the following question answered on a four-point scale (1=poor; 4=excellent): “In general, how would you rate your overall health?”
Full text: Click here
Publication 2017
Biological Factors Cardiovascular Diseases Cardiovascular System Cognition Depressive Symptoms Diabetes Mellitus Disabled Persons Disease, Chronic Ethnicity Ex-Smokers Face Fatigue Feelings Friend Households Index, Body Mass Lethargy Malignant Neoplasms Memory Military Personnel Mood Neoplasms Pressure, Diastolic Psychological Factors Student Systole Touch Perception

Most recents protocols related to «Lethargy»

Not available on PMC !

Example 13

The instant study is designed to test the efficacy in cotton rats of candidate hMPV vaccines against a lethal challenge using an hMPV vaccine comprising mRNA encoding Fusion (F) glycoprotein, major surface glycoprotein G, or a combination of both antigens obtained from hMPV. Cotton rats are challenged with a lethal dose of the hMPV.

Animals are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) at week 0 and week 3 with candidate hMPV vaccines with and without adjuvant. Candidate vaccines are chemically modified or unmodified. The animals are then challenged with a lethal dose of hMPV on week 7 via IV, IM or ID. Endpoint is day 13 post infection, death or euthanasia. Animals displaying severe illness as determined by >30% weight loss, extreme lethargy or paralysis are euthanized. Body temperature and weight are assessed and recorded daily.

In experiments where a lipid nanoparticle (LNP) formulation is used, the formulation may include a cationic lipid, non-cationic lipid, PEG lipid and structural lipid in the ratios 50:10:1.5:38.5. The cationic lipid is DLin-KC2-DMA (50 mol %) or DLin-MC3-DMA (50 mol %), the non-cationic lipid is DSPC (10 mol %), the PEG lipid is PEG-DOMG (1.5 mol %) and the structural lipid is cholesterol (38.5 mol %), for example.

Full text: Click here
Patent 2024
Animals Antigens Body Temperature Cations Cholesterol Euthanasia Glycoproteins Human Metapneumovirus Infection Lethargy Lipid Nanoparticles Lipids Membrane Glycoproteins Pharmaceutical Adjuvants Rats, Cotton RNA, Messenger Rodent Vaccines
Not available on PMC !

Example 18

The instant study is designed to test the efficacy in cotton rats of candidate PIV3 vaccines against a lethal challenge using a PIV3 vaccine comprising mRNA encoding hemagglutinin-neuraminidase or fusion protein (F or F0) obtained from PIV3. Cotton rats are challenged with a lethal dose of the PIV3.

Animals are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) at week 0 and week 3 with candidate PIV3 vaccines with and without adjuvant. Candidate vaccines are chemically modified or unmodified. The animals are then challenged with a lethal dose of PIV3 on week 7 via IV, IM or ID. Endpoint is day 13 post infection, death or euthanasia. Animals displaying severe illness as determined by >30% weight loss, extreme lethargy or paralysis are euthanized. Body temperature and weight are assessed and recorded daily.

In experiments where a lipid nanoparticle (LNP) formulation is used, the formulation may include a cationic lipid, non-cationic lipid, PEG lipid and structural lipid in the ratios 50:10:1.5:38.5. The cationic lipid is DLin-KC2-DMA (50 mol %) or DLin-MC3-DMA (50 mol %), the non-cationic lipid is DSPC (10 mol %), the PEG lipid is PEG-DOMG (1.5 mol %) and the structural lipid is cholesterol (38.5 mol %), for example.

Full text: Click here
Patent 2024
Animals Body Temperature Cations Cholesterol Euthanasia Hemagglutinin Infection Lethargy Lipid Nanoparticles Lipids Neuraminidase Pharmaceutical Adjuvants Proteins Rats, Cotton RNA, Messenger Rodent Vaccines
All studies were approved by the IACUC of Texas Tech University Health Sciences Center, Lubbock, Texas (IACUC protocol# 20026). Experiments were performed in accordance with relevant guidelines and regulations. Female CD1 pregnant mice (Charles River Laboratories, Inc., Wilmington, MA; Cat# CRL: 22, RRID: IMSR_CRL:22) and after delivery their offspring were kept under standardized light and dark conditions (12 h), humidity (70%), and temperature (22 °C). Pregnant mice were singly housed. Offspring were separated into male and female after weaning (postnatal day 21–22) and housed in a group of 2–5. They were given ad libitum access to food and water. Animal behavior was monitored daily to minimize animal suffering. We applied the following exclusion criteria to our experiments: severe weight loss, infections, or significant behavioral deficits (decreased mobility, seizures, lethargy). No animal was excluded from this study. The research design is depicted in Fig. 1. A total number of 176 (n = 16 for mother and n = 160 for offspring) mice were used to perform this study. All experiments were conducted in compliance with the ARRIVE guidelines.

Study design. Pregnant CD1 were exposed to Blu e-cigarette from gestational day 5 (E5) to postnatal day 7 (PD7). At the end of the exposure, plasma nicotine and cotinine level were measured by LCMS/MS, and body weight was measured at PD7, PD23, PD45 and PD90. Mice were sacrificed and brain was extracted at every time point to evaluate blood-brain barrier (BBB) integrity by western blot and immunofluorescence. Open field test, novel object recognition test and morris water maze test were conducted at adolescent and adult time point to evaluate hyperactivity and learning-memory function

Full text: Click here
Publication 2023
Adult Animals Body Weight Brain Cotinine Females Fluorescent Antibody Technique Food Humidity Infection Institutional Animal Care and Use Committees Laser Capture Microdissection Lethargy Light Males Memory Mice, House Morris Water Maze Test Mothers Nicotine Novel Object Recognition Test Obstetric Delivery Open Field Test Plasma Pregnancy Range of Motion, Articular Rivers Seizures Western Blot
Four symptoms of sickness behavior (piloerection, ptosis, lethargy, and huddling; Kelley et al., 2003 (link)) were monitored and recorded each hour for 6 h following the administration of LPS (1.0 mg/kg) and vehicle in 8 rats per treatment condition (four per phenotype). The researchers observing sickness behavior were blinded to the phenotype. At each time point, the presence of absence of these four symptoms was recorded. Piloerection was marked when the animals’ body hair stood up, eyelid drooping was scored as ptosis, lethargy was scored if a rat did not approach the front of the home cage when approached by the researcher, and hunched or curled body posture was marked as huddling.
Full text: Click here
Publication 2023
Animals Behavioral Symptoms Blepharoptosis Hair Human Body Lethargy Phenotype Piloerection
In addition to the determination of brain CHT ubiquitination levels and concentrations of cytokines and chemokines (below) in STs and GTs, the effects of activation of the innate immune system by the bacterial endotoxin lipopolysaccharide (LPS) were assessed. LPS, from Escherichia coli (serotype O111:B4), was obtained from Millipore Sigma and suspended in 0.9% saline (Teknova 0.9% sterile saline solution; Fisher Scientific) vortexed, allocated to 1.0 mg/ml, and stored in 1.5 ml Eppendorf tubes at −20°C until used. Preparation and injections of LPS were conducted in a chemical fume hood and using procedures approved by the University of Michigan Environment, Health and Safety Department.
STs and GTs were randomly assigned to the administration of LPS (1.0 or 5.0 mg/kg in 0.2 ml saline, i.p.) or 0.9% saline. Sickness behaviors, including piloerection, ptosis, lethargy, and huddling were monitored each hour for 6 h following the treatment injection. A lethal dose of sodium pentobarbital was administered (1.5 g/kg, i.p.) 6 h after injections, followed by transcardiac perfusion with 0.9% saline. The right frontal cortex and right striatum were dissected out and synaptosomal pellets were prepared for determination of CHT ubiquitination levels as described above. Furthermore, spleen, left frontal cortex, and left striatum were harvested, flash-frozen in 2-methyl butane, and stored at −80°C for subsequent determination of cytokine and chemokine levels.
Full text: Click here
Publication 2023
Brain Chemokine Cytokine Endotoxins Escherichia coli Freezing isopentane Lethargy Lipopolysaccharides Lobe, Frontal Normal Saline Pellets, Drug Pentobarbital Sodium Perfusion Piloerection Prolapse Safety Saline Solution Spleen Sterility, Reproductive Striatum, Corpus Synaptosomes System, Immune Ubiquitination

Top products related to «Lethargy»

Sourced in United States, Montenegro, Canada, China, France, United Kingdom, Japan, Germany
C57BL/6 mice are a widely used inbred mouse strain commonly used in biomedical research. They are known for their black coat color and are a popular model organism due to their well-characterized genetic and physiological traits.
Sourced in China, United States, Germany, United Kingdom, Canada, Japan, France, Italy, Morocco, Spain, Netherlands, Montenegro, Belgium, Portugal, Ireland, Hungary
The C57BL/6 mouse is a widely used inbred mouse strain. It is a common laboratory mouse model utilized for a variety of research applications.
Sourced in China, United States, Germany, Japan, Canada, United Kingdom, France, Italy, Spain
BALB/c mice are an inbred strain of laboratory mice commonly used in scientific research. They are a widely utilized model organism for various experiments and studies. The BALB/c strain is known for its susceptibility to certain diseases and its ability to produce high levels of antibodies, making it a valuable tool for immunological research.
Sourced in United States, Montenegro
The NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ is a mouse strain. It is a severe combined immunodeficiency (SCID) model with a targeted mutation in the Il2rg gene, which encodes the common gamma chain of the interleukin-2 receptor.
Sourced in United States, United Kingdom, Germany, China, Canada, Japan, Italy, France, Belgium, Australia, Uruguay, Switzerland, Israel, India, Spain, Denmark, Morocco, Austria, Brazil, Ireland, Netherlands, Montenegro, Poland
Matrigel is a solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins. It is widely used as a substrate for the in vitro cultivation of cells, particularly those that require a more physiologically relevant microenvironment for growth and differentiation.
Sourced in United States, China, Canada, United Kingdom, Germany, Italy, France, Japan, Spain
CD-1 mice are a widely used outbred mouse strain that exhibit genetic diversity. They are suitable for a variety of research applications due to their adaptability and lack of specific genetic modifications.
Sourced in United States, Montenegro, Germany, United Kingdom, Japan, China, Canada, Australia, France, Colombia, Netherlands, Spain
C57BL/6J is a mouse strain commonly used in biomedical research. It is a common inbred mouse strain that has been extensively characterized.
Sourced in United States, Montenegro, Japan, Canada, United Kingdom, Germany, Macao, Switzerland, China
C57BL/6J mice are a widely used inbred mouse strain. They are a commonly used model organism in biomedical research.
Sourced in United States, Germany, Italy, United Kingdom, Denmark, Belgium
D-luciferin is a chemical compound used in bioluminescence research applications. It is the substrate for the luciferase enzyme, which catalyzes the oxidation of D-luciferin to produce light. This light emission can be detected and measured to study various biological processes.
Sourced in United States
The Comprehensive Lab Animal Monitoring System is a device designed to monitor various physiological parameters of laboratory animals. It collects data on factors such as animal activity, body temperature, and other relevant metrics. The system is capable of continuous monitoring and data recording to support research and experimental applications.

More about "Lethargy"

Lethargy, a state of abnormal drowsiness, sluggishness, or lack of energy, can be a symptom of various underlying conditions.
It can interfere with daily activities and negatively impact quality of life.
Effective treatment often involves identifying and addressing the root cause, such as infection, hypothyroidism, depression, or chronic fatigue syndrome.
Overcoming lethargy is crucial for research reproducibility and accuracy.
PubCompare.ai's AI-driven platform can help researchers easily locate protocols from literature, pre-prints, and patents, and use intelligent comparisons to identify the best protocols and products for their needs.
This can be particularly relevant for studies involving C57BL/6 mice, BALB/c mice, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice, Matrigel, CD-1 mice, C57BL/6J mice, and the use of D-luciferin in Comprehensive Lab Animal Monitoring Systems.
Proper rest, hydration, and management of any underlying conditions are often recommended to restore energy levels.
Seeking medical evaluation is advisable if lethargy persists or interferes with normal functioning.
By taking the guesswork out of research, PubCompare.ai can help researchers overcome lethargy and boost the reproducibility and accuracy of their studies.